These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3495637)

  • 41. Epidemiological investigations into multiple sclerosis in Southern Hesse. V. Course and prognosis.
    Lauer K; Firnhaber W
    Acta Neurol Scand; 1987 Jul; 76(1):12-7. PubMed ID: 3498287
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Excess mortality and cause of death in a cohort of Norwegian multiple sclerosis patients.
    Smestad C; Sandvik L; Celius EG
    Mult Scler; 2009 Nov; 15(11):1263-70. PubMed ID: 19812114
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term prognosis of multiple sclerosis in Australia.
    McLeod JG; Barnett MH; Macaskill P; Williams DB
    J Neurol Sci; 2007 May; 256(1-2):35-8. PubMed ID: 17368674
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiple sclerosis: disability and mortality in a cohort of clinically diagnosed patients.
    Citterio A; Azan G; Bergamaschi R; Erbetta A; Cosi V
    Neuroepidemiology; 1989; 8(5):249-53. PubMed ID: 2530458
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic factors for survival in multiple sclerosis.
    Lević ZM; Dujmović I; Pekmezović T; Jarebinski M; Marinković J; Stojsavljević N; Drulović J
    Mult Scler; 1999 Jun; 5(3):171-8. PubMed ID: 10408717
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incidence of multiple sclerosis in the Republic of Ireland: A prospective population-based study.
    O'Connell K; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2017 Apr; 13():75-80. PubMed ID: 28427707
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiple sclerosis survival: a population-based study in Sicily.
    Ragonese P; Aridon P; Mazzola MA; Callari G; Palmeri B; Famoso G; Terruso V; Salemi G; D'Amelio M; Savettieri G
    Eur J Neurol; 2010 Mar; 17(3):391-7. PubMed ID: 19863646
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disability and mortality in a cohort of multiple sclerosis patients: a reappraisal.
    Bergamaschi R; Montomoli C; Candeloro E; Fratti C; Citterio A; Cosi V
    Neuroepidemiology; 2005; 25(1):15-8. PubMed ID: 15855800
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early prognostic factors for disability in multiple sclerosis, a European multicenter study.
    Riise T; Grønning M; Fernández O; Lauer K; Midgard R; Minderhoud JM; Nyland H; Pálffy G; Poser S; Aarli JA
    Acta Neurol Scand; 1992 Mar; 85(3):212-8. PubMed ID: 1575007
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical features and disability progression in multiple sclerosis in Tunisia: do we really have a more aggressive disease course?
    Sidhom Y; Damak M; Riahi A; Hizem Y; Mrissa R; Mhiri C; Gouider R
    J Neurol Sci; 2014 Aug; 343(1-2):110-4. PubMed ID: 24980939
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Course of illness and prognosis of multiple sclerosis. 1: The natural illness course].
    Flachenecker P; Hartung HP
    Nervenarzt; 1996 Jun; 67(6):435-43. PubMed ID: 8767197
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Patients with multiple sclerosis among the Lódź population. I. Verification of the diagnosis and clinical characteristics].
    Drabkowska-Kaczmarek A; Bogdańska U; Nowicka K
    Neurol Neurochir Pol; 1985; 19(1):1-8. PubMed ID: 4022234
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Excess mortality among patients with multiple sclerosis in Denmark has dropped significantly over the past six decades: a population based study.
    Koch-Henriksen N; Laursen B; Stenager E; Magyari M
    J Neurol Neurosurg Psychiatry; 2017 Aug; 88(8):626-631. PubMed ID: 28705951
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prognosis and life expectancy in multiple sclerosis].
    Angstwurm H
    Versicherungsmedizin; 1991 Apr; 43(2):52-4. PubMed ID: 2058080
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pediatric-onset multiple sclerosis in Brazilian patients: Clinical features, treatment response and comparison to pediatric neuromyelitis optica spectrum disorders.
    Fragomeni MO; Bichuetti DB; Oliveira EML
    Mult Scler Relat Disord; 2018 Oct; 25():138-142. PubMed ID: 30075406
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term clinical relevance of criteria for designating multiple sclerosis as benign after 10 years of disease.
    Costelloe L; Thompson A; Walsh C; Tubridy N; Hutchinson M
    J Neurol Neurosurg Psychiatry; 2008 Nov; 79(11):1245-8. PubMed ID: 18477712
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suicide and multiple sclerosis: an epidemiological investigation.
    Stenager EN; Stenager E; Koch-Henriksen N; Brønnum-Hansen H; Hyllested K; Jensen K; Bille-Brahe U
    J Neurol Neurosurg Psychiatry; 1992 Jul; 55(7):542-5. PubMed ID: 1640228
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of multiple sclerosis in Rochdale.
    Shepherd DI; Summers A
    J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):415-7. PubMed ID: 8890784
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis: a systematic review.
    Langer-Gould A; Popat RA; Huang SM; Cobb K; Fontoura P; Gould MK; Nelson LM
    Arch Neurol; 2006 Dec; 63(12):1686-91. PubMed ID: 17172607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.